MediWound (MDWD) Interest & Investment Income (2013 - 2026)
MediWound (MDWD) posted quarterly Interest & Investment Income of $429000.0 for Q2 2025, down 26.29% year-over-year from $582000.0 in Q2 2024, and down 26.29% quarter-over-quarter from $582000.0 in Q2 2024.
MediWound (MDWD) Interest & Investment Income (2013 - 2026) Analysis & Trends
MediWound's Interest & Investment Income history runs 13 years deep, the most recent figure standing at $429000.0 for Q2 2025.
- In Q2 2025, Interest & Investment Income fell 26.29% year-over-year to $429000.0; the TTM figure through Jun 2025 stood at $6.9 million (up 5.06% YoY), while the FY2025 annual figure was $4.0 million, up 96.14% from the prior year.
- Interest & Investment Income for Q2 2025 stood at $429000.0, down from $582000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $5.8 million in Q2 2023, with the low at $11000.0 in Q1 2021.
- The 5-year median for Interest & Investment Income is $109500.0 (2021), against an average of $737600.0.
- The sharpest annual moves came in 2021 and 2023: Interest & Investment Income slumped 95.4% in 2021, then surged 52881.82% in 2023.
- MediWound's Interest & Investment Income stood at $101000.0 in 2021, then tumbled by 40.59% to $60000.0 in 2022, then surged by 9613.33% to $5.8 million in 2023, then slumped by 90.01% to $582000.0 in 2024, then slipped by 26.29% to $429000.0 in 2025.
- Business Quant data shows MDWD's Interest & Investment Income at $429000.0 in Q2 2025, $582000.0 in Q2 2024, and $5.8 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | 3.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.22 Mn |
| Jun 30, 2025 | 429,000.00 |
| Jun 30, 2024 | 582,000.00 |
| Jun 30, 2023 | 5.83 Mn |
| Dec 31, 2022 | 60,000.00 |
| Sep 30, 2022 | 97,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 139,000.00 |
| Dec 31, 2021 | 101,000.00 |
| Jun 30, 2021 | 118,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Dec 31, 2020 | -203,000.00 |
| Sep 30, 2020 | 93,000.00 |
| Jun 30, 2020 | 101,000.00 |
| Mar 31, 2020 | 239,000.00 |
| Dec 31, 2019 | -100,000.00 |
| Sep 30, 2019 | 147,000.00 |
| Jun 30, 2019 | 92,000.00 |
| Mar 31, 2019 | 61,000.00 |
| Dec 31, 2018 | 113,000.00 |